Art Pappas

Art Pappas

Vorstandsvorsitzender bei
Pappas Capital LLC
78 Jahre
Health Technology
Finance
Commercial Services

Profil

Art M.
Pappas
founded Pappas Capital Management in 1994, CoLucid Pharmaceuticals, Inc. in 2005, where he worked as Chairman, and Pappas Capital LLC in 1994, where he is working as Managing Partner from 1994.
Mr. Pappas also currently works at MUSC Foundation for Research Development, as Director, Real Endpoints LLC, as Director, OrphoMed, Inc., as Director, and various other companies.
Mr. Pappas also formerly worked at Merrell Dow USA, as Chief Executive Officer-Brazil Region, Glaxo Far East Pte Ltd., as Chief Executive Officer in 1994, Merrell Dow Pharmaceuticals Pacific Ltd., as Chief Executive Officer, and various other companies.
Mr. Pappas received his Masters Business Admin degree from Xavier University and undergraduate degree from The Ohio State University.

Aktive Positionen von Art Pappas

UnternehmenPositionBeginn
Vorstandsvorsitzender 01.04.1994
Corporate Officer/Principal 15.05.2013
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Private Equity Investor -
Berater -
MUSC Foundation for Research Development
Direktor/Vorstandsmitglied -
░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Art Pappas

UnternehmenPositionEnde
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Art Pappas im Detail an

Ausbildung von Art Pappas

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

65

Beziehungen ersten Grades

42

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen42

Process Industries

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Commercial Services

Health Technology

Technology Services

Commercial Services

MUSC Foundation for Research Development

Finance

Merrell Dow USA

Glaxo Far East Pte Ltd.

Commercial Services

Technology Services

Finance

Distribution Services

Health Technology

Finance

Health Technology

Finance

Merrell Dow Pharmaceuticals Pacific Ltd.

Finance

Finance

Health Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Art Pappas
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT